ID
32947
Description
Study ID: 107085 Clinical Study ID: GLP107085 Study Title: A Randomized, Double-blind, Parallel, Nested Crossover Study to Investigate the Effect of Albiglutide on Cardiac Repolarization (corrected QT Interval) Compared With Placebo in Healthy Male and Female Subjects: A Thorough ECG Study Employing Placebo, Albiglutide, and a Positive Control (Moxifloxacin) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01406262 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: albiglutide Trade Name: Tanzeum,Eperzan Study Indication: Diabetes Mellitus, Type 2
Keywords
Versions (1)
- 11/21/18 11/21/18 -
Copyright Holder
GSK group of companies
Uploaded on
November 21, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
The Effect of Albiglutide on Cardiac Repolarisation Compared with Placebo 107085
Liver Imaging Form 2
- StudyEvent: ODM
Description
Liver Size
Description
Liver texture
Description
Diffuse and Geographic Fatty Infiltrate
Description
Ascites present
Description
Focal Hepatic Lesions
Description
Gallstones or gallbladder lesions
Description
Gallstones or gallbladder lesions?
Data type
text
Description
If Other, specify
Data type
text
Description
Biliary Ductal Lesions
Description
Biliary ductal lesions
Data type
text
Description
If Other, specify
Data type
text
Description
Abnormalities
Description
Portal/Hepatic Vein Abnormalities
Data type
text
Description
If Other, specify
Data type
text
Similar models
Liver Imaging Form 2
- StudyEvent: ODM